Pathstone Family Office’s Covetrus, Inc. Common Stock CVET Stock Holding History

Pathstone Family Office’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,658	Closed	-$452K	–	1633
2022 Q3	$452K	Buy	+21,658	New	+$451K	﹤0.01%	1117
2021 Q1	–	Sell	-1,492	Closed	-$43K	–	1437
2020 Q4	$43K	Hold	1,492	–	–	﹤0.01%	548
2020 Q3	$36K	Hold	1,492	–	–	﹤0.01%	402
2020 Q2	$27K	Hold	1,492	–	–	﹤0.01%	390
2020 Q1	$12K	Buy	+1,492	New	+$17K	﹤0.01%	509
2019 Q4	–	Sell	-1,492	Closed	-$17K	–	657
2019 Q3	$17K	Hold	1,492	–	–	﹤0.01%	421
2019 Q2	$36K	Sell	1,492 -22	-1%	-$634	﹤0.01%	372
2019 Q1	$49K	Buy	+1,514	New	+$53.7K	0.01%	309

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pathstone Family Office's CVET Position: Q4 2022 in Review

Pathstone Family Office sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 21,658 shares — an estimated $452K sold.

Pathstone Family Office first reported a position in CVET in Q1 2019 and held it in 8 quarters. The position peaked at $452K in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Pathstone Family Office reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Pathstone Family Office sold 21,658 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $452K.
Pathstone Family Office first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 8 quarters.
Pathstone Family Office's Covetrus, Inc. Common Stock position peaked at $452K in Q3 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.